Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and salicylates

9,10-dimethyl-1,2-benzanthracene has been researched along with salicylates in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Rey, BM; Durán, HA1
Colby, AB; Reiners, JJ1
Logani, MK; Slaga, TJ; Solanki, V; Yotti, L1
de Rey, BM; Durán, HA; Lanfranchi, H; Palmieri, MA1
George, J; Kuttan, R1
Abbadessa, G; Dacasto, M; Di Carlo, F; Nebbia, C; Racca, S; Sartori, ML; Spaccamiglio, A1

Other Studies

6 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and salicylates

ArticleYear
Differential oxidative stress induced by two different types of skin tumor promoters, benzoyl peroxide and 12-O-tetradecanoylphorbol-13-acetate.
    Carcinogenesis, 1991, Volume: 12, Issue:11

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoyl Peroxide; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Luminescent Measurements; Mice; Mice, Inbred Strains; Oxidation-Reduction; Salicylates; Skin; Tetradecanoylphorbol Acetate

1991
Survey of cytotoxicities and antimutagenic and antitumor initiating activities of Cu(II)(3,5-diisopropylsalicylate)2 and its analogs in a keratinocyte-mediated mutation assay and the murine skin multistage carcinogenesis model.
    Carcinogenesis, 1988, Volume: 9, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzo(a)pyrene; Cell Line; Cell Survival; Cells, Cultured; Copper; Copper Sulfate; Epidermal Cells; Epidermis; Mice; Mice, Inbred Strains; Mutation; Papilloma; Salicylates; Skin Neoplasms

1988
The reduction of tumor initiating activity and cell mediated mutagenicity of dimethylbenz[a]anthracene by a copper coordination compound.
    Carcinogenesis, 1984, Volume: 5, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Biotransformation; Cocarcinogenesis; Cricetinae; Female; Mice; Salicylates; Skin Neoplasms

1984
Inhibition of benzoyl peroxide-induced tumor promotion and progression by copper(II)(3,5-diisopropylsalicylate)2.
    Cancer letters, 1993, May-14, Volume: 69, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Benzoyl Peroxide; Carcinoma, Squamous Cell; Cocarcinogenesis; Female; Incidence; Keratoacanthoma; Mice; Papilloma; Salicylates; Skin Neoplasms

1993
Mutagenic, carcinogenic and cocarcinogenic activity of cashewnut shell liquid.
    Cancer letters, 1997, Jan-15, Volume: 112, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Anacardic Acids; Animals; Carcinogenicity Tests; Carcinogens; Cocarcinogenesis; Female; Mice; Mutagenicity Tests; Neoplasms, Experimental; Plant Extracts; Plants, Toxic; Resorcinols; Salicylates; Salmonella typhimurium; Skin Neoplasms

1997
The aspirin metabolite, salicylate, inhibits 7,12-dimethylbenz[a]anthracene-DNA adduct formation in breast cancer cells.
    International journal of oncology, 2006, Volume: 28, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP1A1; DNA Adducts; Female; Humans; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Salicylates

2006